Skip to main content
. 2020 Apr 28;11(17):1515–1530. doi: 10.18632/oncotarget.27566

Table 3. List of ten genes with significant differences in all four groups (p < 0.05).

mRNA HIGH1-HIGH2 (n) HIGH1-LOW2 (n) LOW1-HIGH2 (n) LOW1-LOW2 (n) mRNA2 p-value Confidence level
FBLN1 132 440 440 892 8.68619E-07 High
ADSS 128 444 444 888 1.7E-05 Low
PDCD4 205 367 367 965 7.37794E-06 Low
CC2D1A 212 360 360 972 1.13348E-05 Low
TACC3 141 431 431 901 1.396E-05 Low
USP15 188 384 384 948 1.5364E-05 Low
HMGN2 204 368 368 964 1.61573E-05 Low
LARS 195 377 377 955 1.64125E-05 Low
ADSS 128 444 444 888 1.69623E-05 Low
RAB25 188 384 384 948 1.76618E-05 Low

The values in columns 2–5 denote the number of patients in each group.